Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure

J Med Virol. 1999 Aug;58(4):373-7.

Abstract

GB virus C (GBV-C) or hepatitis G virus (HGV) is transmitted by the parenteral route but the importance of sexual transmission needs to be ascertained. GBV-C/HGV infections were investigated using RNA and E2-antibody detection methods in 80 subjects infected by the human immunodeficiency virus type 1 (HIV-1) divided into 4 groups of 20 individuals each according to their main risk factor for HIV-1 infection: blood product recipients (group 1), intravenous drug users (group 2), homosexuals (group 3), or heterosexual exposure (group 4). The overall prevalence of GBV-C/HGV infection was 66.3%. No significant difference was observed in GBV-C/ HGV prevalence among the four groups: 75, 75, 55, and 60% in groups 1, 2, 3, and 4, respectively. Hepatitis C virus (HCV) antibodies, used as a control for parenteral exposure, were found in 70% and 90% of the subjects in groups 1 and 2 versus only 15% and 20% of the subjects in groups 3 and 4, respectively (P< .001). Similarly, coinfections with GBV-C/HGV and HCV were significantly associated with the parenteral route (P <.001). These data emphasized the usefulness of combining the detection of RNA and the E2 antibody to determine the actual prevalence of GBV-C/HGV infection. The high prevalence of the GBV-C/HGV markers among the HIV-1-infected subjects, especially those with sexual exposure, provides additional evidence that this route of transmission plays a key role in the epidemiology of GBV-C/HGV. The potential influence of GBV-C/HGV infection on the course of HIV-1 disease needs further evaluation.

MeSH terms

  • Adult
  • Drug Administration Routes
  • Female
  • Flaviviridae / genetics*
  • Flaviviridae / immunology
  • France / epidemiology
  • HIV Infections / complications*
  • HIV Infections / transmission
  • HIV-1*
  • Hepatitis Antibodies / blood*
  • Hepatitis Antibodies / immunology
  • Hepatitis, Viral, Human / complications
  • Hepatitis, Viral, Human / epidemiology
  • Hepatitis, Viral, Human / virology*
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral / blood
  • RNA, Viral / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sexually Transmitted Diseases, Viral / transmission
  • Viral Envelope Proteins / immunology
  • Viral Nonstructural Proteins / genetics

Substances

  • Hepatitis Antibodies
  • RNA, Viral
  • Viral Envelope Proteins
  • Viral Nonstructural Proteins
  • glycoprotein E2, GB virus C
  • p58 protein, classical swine fever virus